Phaseline

Companies › Corvus Pharmaceuticals

Corvus Pharmaceuticals: clinical trials, targets and expected readouts

2 active drug programs in 5 registered trials: 2 Phase 2, 2 Phase 1, 1 Phase 3; Oncology, Immunology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Soquelitinib
ITK inhibitor
ITKPhase 3Peripheral T-Cell Lymphoma, Not Otherwise Specified; Atopic Dermatitis; Hidradenitis Suppurativa (HS); Autoimmune Lymphoproliferative SyndromeJun 2027
CPI-818
Interleukin-2 inducible T-cell kinase (ITK) inhibitor
ITKPhase 1T-cell LymphomaDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06730126SoquelitinibPhase 2Autoimmune Lymphoproliferative SyndromeImmunologyDec 2026
NCT03952078CPI-818Phase 1T-cell LymphomaOncologyDec 2026
NCT07441395SoquelitinibPhase 2Atopic DermatitisImmunologyJun 2027
NCT06561048SoquelitinibPhase 3Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedOncologyNov 2027
NCT07828860SoquelitinibPhase 1Hidradenitis Suppurativa (HS)ImmunologyDec 2027

From the company's SEC filings

Cash and short-term investments of $203m on 2026-09-30; operating cash outflow about $51m a year; runway about 48 months at that burn, to Sep 2030; 3 of 3 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Specialist investors

Held by 8 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

ITK (2)

Companies with the same targets

Pfizer

Companies built like this

Zai Lab (Shanghai) Nuvation Bio Sellas Life Sciences Group Ascentage Pharma Group Ganzhou Hemay Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.